deferoxamine has been researched along with Toxoplasmosis, Animal in 1 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.
Excerpt | Relevance | Reference |
---|---|---|
" Three doses of 200, 300 and 400 mg/kg DFO were used either alone or in combination with pyrimethamine." | 1.30 | Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice. ( Mahmoud, MS, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahmoud, MS | 1 |
1 other study available for deferoxamine and Toxoplasmosis, Animal
Article | Year |
---|---|
Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Deferoxamine; Disease Models, Animal; Drug Therapy, Co | 1999 |